Benefits of Participating

Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; be recognized for leadership.

Who is Included

National associations representing physicians, NPs, dentists and other care-team partners who prescribe or help manage medications are invited to participate as Institutional Study Partners. These may include:

• • American Medical Association

  • American Academy of Family Physicians

  • American Nurses Association

  • American Geriatrics Society

  • Specialty Medical Societies concerned about medication use

  • American Dental Society

  • Other relevant national associations (based on discussion)

Benefits of Participating

Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; be recognized for leadership.

Who is Included

Large US physician organizations and other clinical organizations and networks with state, regional or national footprints, with enough market power to help influence change in their relevant networks are invited as organizational study partners. These may include:

• Independent Primary Care Networks

• Specialty Physician Networks

• Specialty Care Networks

• Convenient Care Networks

• Federally Qualified Health Centers (FQHCs)

• Telehealth networks

Benefits of Participating

Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; be recognized for leadership.

Who is Included

Senior leaders able to speak for their institutions or organizations along with their designees and support staff are invited as participants and/or observers. The goal is to have senior leaders who can make strategic decisions for their organizations actively engaged to help achieve transformational action.

Titles along the following lines are welcome:

• Board Member

• President/CEO

• Chief XYZ Officer (Medical, Pharmacy, Nursing, Quality, Strategy, Operations, etc.)

• Senior Vice President / Vice President

• Director

Senior leaders are welcome to invite designees to join or represent them. Support staff, assistants, and interns are also welcome to join as observers or proxies to assist in decision-making.

Who is Included

Established researchers with academic affiliations and relevant expertise in this area are encouraged to join. Assistance in facilitating "boats" and "sections", co-investigation opportunities, and other opportunities are available. Researchers working in foundations, associations or research divisions of organizations are also welcome.

Learn more here.